Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy. [PDF]
Zhu XY, Zhou WY, Li T.
europepmc +1 more source
Quantitative analysis of orbital soft tissue for the detection of dysthyroid optic neuropathy in patients with thyroid-associated ophthalmopathy, based on three-dimensional cube fast spin-echo Flex. [PDF]
Liang W +9 more
europepmc +1 more source
Orbital computed tomography imaging characteristics of thyroid-associated ophthalmopathy. [PDF]
Xiong C +7 more
europepmc +1 more source
What is the psychological impact of thyroid eye disease and does orbital decompression surgery improve outcomes? [PDF]
Wickwar, S.
core
Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy. [PDF]
Huang Z, Xu M, Zhang W, Song X.
europepmc +1 more source
Thyroid-associated ophthalmopathy and ferroptosis: a review of pathological mechanisms and therapeutic strategies. [PDF]
Ma C, Li H, Lu S, Li X.
europepmc +1 more source
Can chimeric antigen receptorsĀ - based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases? [PDF]
Zhou W, Zhu X, Shi Y.
europepmc +1 more source
Correlation between orbital imaging features of thyroid-associated ophthalmopathy and pupillary light reflex measurement. [PDF]
Li Y, Zhu Z, Lu Y, Lin Q, Liu M, Li Z.
europepmc +1 more source
Monocyte to high-density lipoprotein cholesterol ratio as a predictor of the activity of thyroid-associated ophthalmopathy. [PDF]
Sun XH +7 more
europepmc +1 more source
In Vitro Investigation of HIF-1α as a Therapeutic Target for Thyroid-Associated Ophthalmopathy. [PDF]
Lee J +9 more
europepmc +1 more source

